345 related articles for article (PubMed ID: 17279554)
21. Membrane type 1-matrix metalloproteinase (MMP)-associated MMP-2 activation increases in the rat ovary in response to an ovulatory dose of human chorionic gonadotropin.
Jo M; Thomas LE; Wheeler SE; Curry TE
Biol Reprod; 2004 Apr; 70(4):1024-32. PubMed ID: 14668206
[TBL] [Abstract][Full Text] [Related]
22. Increases in matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 mRNA after cerebral contusion and depolarisation.
von Gertten C; Holmin S; Mathiesen T; Nordqvist AC
J Neurosci Res; 2003 Sep; 73(6):803-10. PubMed ID: 12949906
[TBL] [Abstract][Full Text] [Related]
23. The role of TNF-alpha and its receptors in the production of Src-suppressed C kinase substrate by rat primary type-2 astrocytes.
Yan M; Xia C; Cheng C; Shao X; Niu S; Liu H; Shen A
Brain Res; 2007 Dec; 1184():28-37. PubMed ID: 17980351
[TBL] [Abstract][Full Text] [Related]
24. Fibrosis and matrix metalloproteinases in rat renal allografts.
Inkinen KA; Soots AP; Krogerus LA; Lautenschlager IT; Ahonen JP
Transpl Int; 2005 May; 18(5):506-12. PubMed ID: 15819797
[TBL] [Abstract][Full Text] [Related]
25. Cytokine-mediated modulation of MMPs and TIMPs in multipotential neural precursor cells.
Ben-Hur T; Ben-Yosef Y; Mizrachi-Kol R; Ben-Menachem O; Miller A
J Neuroimmunol; 2006 Jun; 175(1-2):12-8. PubMed ID: 16580738
[TBL] [Abstract][Full Text] [Related]
26. Induction of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs correlates with outcome of acute experimental pseudomonal keratitis.
Ikema K; Matsumoto K; Inomata Y; Komohara Y; Miyajima S; Takeya M; Tanihara H
Exp Eye Res; 2006 Dec; 83(6):1396-404. PubMed ID: 16968651
[TBL] [Abstract][Full Text] [Related]
27. Decreased matrix degradation in diabetic nephropathy: effects of ACE inhibition on the expression and activities of matrix metalloproteinases.
McLennan SV; Kelly DJ; Cox AJ; Cao Z; Lyons JG; Yue DK; Gilbert RE
Diabetologia; 2002 Feb; 45(2):268-75. PubMed ID: 11935159
[TBL] [Abstract][Full Text] [Related]
28. Expression and activation of MMP -2, -3, -9, -14 are induced in rat colon after abdominal X-irradiation.
Strup-Perrot C; Vozenin-Brotons MC; Vandamme M; Benderitter M; Mathe D
Scand J Gastroenterol; 2006 Jan; 41(1):60-70. PubMed ID: 16373278
[TBL] [Abstract][Full Text] [Related]
29. Differential expression of matrix metalloproteinases and tissue inhibitors and extracellular matrix remodeling in aortic regurgitant hearts.
Truter SL; Catanzaro DF; Supino PG; Gupta A; Carter J; Herrold EM; Dumlao TF; Borer JS
Cardiology; 2009; 113(3):161-8. PubMed ID: 19129699
[TBL] [Abstract][Full Text] [Related]
30. Differential vesicular distribution and trafficking of MMP-2, MMP-9, and their inhibitors in astrocytes.
Sbai O; Ould-Yahoui A; Ferhat L; Gueye Y; Bernard A; Charrat E; Mehanna A; Risso JJ; Chauvin JP; Fenouillet E; Rivera S; Khrestchatisky M
Glia; 2010 Feb; 58(3):344-66. PubMed ID: 19780201
[TBL] [Abstract][Full Text] [Related]
31. Effect of angiotensin II receptor blocker on glucose-induced mRNA expressions of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in rat mesangial cells.
Ding HL; Guo Y; Xu MT; Li HY; Fu ZZ
Chin Med J (Engl); 2007 Nov; 120(21):1886-9. PubMed ID: 18067760
[TBL] [Abstract][Full Text] [Related]
32. Brain-derived neurotrophic factor inducing angiogenesis through modulation of matrix-degrading proteases.
Sun CY; Hu Y; Wang HF; He WJ; Wang YD; Wu T
Chin Med J (Engl); 2006 Apr; 119(7):589-95. PubMed ID: 16620701
[TBL] [Abstract][Full Text] [Related]
33. Activation of cartilage matrix metalloproteinases by activated protein C.
Jackson MT; Smith MM; Smith SM; Jackson CJ; Xue M; Little CB
Arthritis Rheum; 2009 Mar; 60(3):780-91. PubMed ID: 19248107
[TBL] [Abstract][Full Text] [Related]
34. Regulation of mRNAs encoding MMP-9 and MMP-2, and their inhibitors TIMP-1 and TIMP-2 by androgens in the rat ventral prostate.
Limaye AM; Desai KV; Chavalmane AK; Kondaiah P
Mol Cell Endocrinol; 2008 Nov; 294(1-2):10-8. PubMed ID: 18675881
[TBL] [Abstract][Full Text] [Related]
35. Expression and activation of pro-MMP-2 and pro-MMP-9 during rat liver regeneration.
Kim TH; Mars WM; Stolz DB; Michalopoulos GK
Hepatology; 2000 Jan; 31(1):75-82. PubMed ID: 10613731
[TBL] [Abstract][Full Text] [Related]
36. Developmental expression of matrix metalloproteinases 2 and 9 and their potential role in the histogenesis of the cerebellar cortex.
Ayoub AE; Cai TQ; Kaplan RA; Luo J
J Comp Neurol; 2005 Jan; 481(4):403-15. PubMed ID: 15593342
[TBL] [Abstract][Full Text] [Related]
37. Canine TIMP-2: purification, characterization and molecular detection.
Bee A; Barnes A; Jones MD; Robertson DH; Clegg PD; Carter SD
Vet J; 2000 Sep; 160(2):126-34. PubMed ID: 10985804
[TBL] [Abstract][Full Text] [Related]
38. Promoted activation of matrix metalloproteinase (MMP)-2 in keloid fibroblasts and increased expression of MMP-2 in collagen bundle regions: implications for mechanisms of keloid progression.
Imaizumi R; Akasaka Y; Inomata N; Okada E; Ito K; Ishikawa Y; Maruyama Y
Histopathology; 2009 May; 54(6):722-30. PubMed ID: 19438747
[TBL] [Abstract][Full Text] [Related]
39. Platelet-derived growth factor and transforming growth factor-beta modulate the expression of matrix metalloproteinases and migratory function of human airway smooth muscle cells.
Ito I; Fixman ED; Asai K; Yoshida M; Gounni AS; Martin JG; Hamid Q
Clin Exp Allergy; 2009 Sep; 39(9):1370-80. PubMed ID: 19522858
[TBL] [Abstract][Full Text] [Related]
40. Activation ratio of MMP-2 and expression of MT1-MMP are correlated in thymic epithelial tumours.
Wang Y; Xu HT; Ueda Y; Shimasaki M; Wang EH
Pathology; 2007 Oct; 39(5):486-90. PubMed ID: 17886098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
